Clinical Trials Directory

Trials / Completed

CompletedNCT04089488

Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America

Prospective Observational Study of Site-Specific Incident and Prevalent Cases of Cancer in People Living With HIV/AIDS- in Latin America

Status
Completed
Phase
Study type
Observational
Enrollment
175 (actual)
Sponsor
AIDS Malignancy Consortium · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial studies the frequency of incident and prevalent of cancer in people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) at cancer centers in Latin America. By counting how many people living with HIV/AIDS have cancer at these specific centers, researchers may better understand how they are being treated and cared for. This may help researchers to understand what new studies may be helpful for those areas in the future.

Detailed description

PRIMARY OBJECTIVES: I. To determine the number of diagnosed cancers in people living with HIV/AIDS (PLWHA) presenting to participating clinical sites in Latin America, and estimate site-specific prevalence based on all presenting cancers (new diagnosis, recurrence, and surveillance cases) and site-specific incidence based on newly diagnosed cancers. SECONDARY OBJECTIVES: I. Obtain information on the use of diagnostic testing and treatment for the cohort of diagnosed HIV-associated cancer participants. II. To collect information on participant characteristics for diagnosed HIV-associated cancers (e.g., antiretroviral therapy \[ART\] regimen, current CD4 count, current viral load, etc.). OUTLINE: Patients respond to surveys and/or undergo medical record review at baseline and at 4 weeks.

Conditions

Interventions

TypeNameDescription
OTHERMedical Chart ReviewCorrelative studies
OTHERSurvey AdministrationRespond to surveys

Timeline

Start date
2020-01-17
Primary completion
2021-10-18
Completion
2021-10-18
First posted
2019-09-13
Last updated
2023-09-01
Results posted
2023-08-22

Locations

4 sites across 3 countries: Argentina, Brazil, Mexico

Source: ClinicalTrials.gov record NCT04089488. Inclusion in this directory is not an endorsement.